nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—hypertension—adrenal gland cancer	0.741	1	CtDrD
Propranolol—ABCB1—adrenal gland cancer	0.235	1	CbGaD
Propranolol—ADRB3—brown adipose tissue—adrenal gland cancer	0.00592	0.546	CbGeAlD
Propranolol—CYP2C19—urine—adrenal gland cancer	0.00123	0.113	CbGeAlD
Propranolol—CYP1A2—urine—adrenal gland cancer	0.001	0.0924	CbGeAlD
Propranolol—CYP3A4—urine—adrenal gland cancer	0.000725	0.0668	CbGeAlD
Propranolol—CYP2D6—urine—adrenal gland cancer	0.000714	0.0658	CbGeAlD
Propranolol—ADRB1—cardiac atrium—adrenal gland cancer	0.000336	0.031	CbGeAlD
Propranolol—Atenolol—ABCB1—adrenal gland cancer	0.000276	0.264	CrCbGaD
Propranolol—Acebutolol—ABCB1—adrenal gland cancer	0.000254	0.243	CrCbGaD
Propranolol—HTR1A—adrenal gland—adrenal gland cancer	0.000251	0.0232	CbGeAlD
Propranolol—CYP1A1—cardiac atrium—adrenal gland cancer	0.000217	0.02	CbGeAlD
Propranolol—Metoprolol—ABCB1—adrenal gland cancer	0.000215	0.205	CrCbGaD
Propranolol—Propafenone—ABCB1—adrenal gland cancer	0.000158	0.151	CrCbGaD
Propranolol—Carvedilol—ABCB1—adrenal gland cancer	0.000142	0.136	CrCbGaD
Propranolol—ABCB1—adrenal cortex—adrenal gland cancer	0.000136	0.0125	CbGeAlD
Propranolol—ABCB1—gonad—adrenal gland cancer	0.000113	0.0104	CbGeAlD
Propranolol—ABCB1—pituitary gland—adrenal gland cancer	0.00011	0.0101	CbGeAlD
Propranolol—ABCB1—adrenal gland—adrenal gland cancer	9.82e-05	0.00905	CbGeAlD
Propranolol—ADRB1—GPCR downstream signaling—TSHR—adrenal gland cancer	2.12e-05	0.00168	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—GNRH1—adrenal gland cancer	2.11e-05	0.00168	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	2.1e-05	0.00167	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	2.1e-05	0.00167	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—GNAS—adrenal gland cancer	2.08e-05	0.00166	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—GNRHR—adrenal gland cancer	2.08e-05	0.00166	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—GNAS—adrenal gland cancer	2.07e-05	0.00165	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—TSHR—adrenal gland cancer	2.07e-05	0.00165	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—GNRH1—adrenal gland cancer	2.06e-05	0.00164	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—GNRHR—adrenal gland cancer	2.03e-05	0.00162	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—TSHR—adrenal gland cancer	2.02e-05	0.00161	CbGpPWpGaD
Propranolol—CYP1A1—Biological oxidations—POMC—adrenal gland cancer	2.02e-05	0.00161	CbGpPWpGaD
Propranolol—SLC22A2—Neuronal System—BRAF—adrenal gland cancer	1.98e-05	0.00158	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.98e-05	0.00158	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SH3KBP1—adrenal gland cancer	1.98e-05	0.00157	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—CDC42—adrenal gland cancer	1.97e-05	0.00157	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—SPRY2—adrenal gland cancer	1.96e-05	0.00156	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	1.95e-05	0.00155	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SH3KBP1—adrenal gland cancer	1.93e-05	0.00154	CbGpPWpGaD
Propranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	1.93e-05	0.00153	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—TSHR—adrenal gland cancer	1.92e-05	0.00153	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—SDHB—adrenal gland cancer	1.91e-05	0.00152	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TSHR—adrenal gland cancer	1.91e-05	0.00152	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	1.89e-05	0.0015	CbGpPWpGaD
Propranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	1.88e-05	0.0015	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—GNAS—adrenal gland cancer	1.88e-05	0.0015	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—TSHR—adrenal gland cancer	1.88e-05	0.0015	CbGpPWpGaD
Propranolol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.87e-05	0.00149	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ZNRF3—adrenal gland cancer	1.86e-05	0.00148	CbGpPWpGaD
Propranolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	1.84e-05	0.00147	CbGpPWpGaD
Propranolol—HTR1B—GPCR ligand binding—POMC—adrenal gland cancer	1.84e-05	0.00147	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—TSHR—adrenal gland cancer	1.84e-05	0.00146	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ZNRF3—adrenal gland cancer	1.82e-05	0.00145	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—SDHB—adrenal gland cancer	1.81e-05	0.00144	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MEN1—adrenal gland cancer	1.8e-05	0.00143	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ZNRF3—adrenal gland cancer	1.78e-05	0.00141	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—PRKACA—adrenal gland cancer	1.73e-05	0.00138	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—RRM1—adrenal gland cancer	1.71e-05	0.00136	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—SDHD—adrenal gland cancer	1.71e-05	0.00136	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—RRM1—adrenal gland cancer	1.7e-05	0.00136	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—SDHD—adrenal gland cancer	1.7e-05	0.00136	CbGpPWpGaD
Propranolol—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	1.66e-05	0.00132	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—CDC42—adrenal gland cancer	1.62e-05	0.00129	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	1.61e-05	0.00128	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.6e-05	0.00128	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—GNRH1—adrenal gland cancer	1.6e-05	0.00127	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	1.6e-05	0.00127	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.57e-05	0.00125	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—GNAS—adrenal gland cancer	1.55e-05	0.00123	CbGpPWpGaD
Propranolol—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	1.52e-05	0.00121	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—SDHB—adrenal gland cancer	1.48e-05	0.00118	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—CDC42—adrenal gland cancer	1.47e-05	0.00117	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—POMC—adrenal gland cancer	1.47e-05	0.00117	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SPRY2—adrenal gland cancer	1.46e-05	0.00116	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—SDHB—adrenal gland cancer	1.44e-05	0.00115	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—POMC—adrenal gland cancer	1.43e-05	0.00114	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TSHR—adrenal gland cancer	1.43e-05	0.00113	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.42e-05	0.00113	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—GNAS—adrenal gland cancer	1.4e-05	0.00112	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—POMC—adrenal gland cancer	1.4e-05	0.00112	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—POMC—adrenal gland cancer	1.4e-05	0.00111	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PRKACA—adrenal gland cancer	1.38e-05	0.0011	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PRKACA—adrenal gland cancer	1.37e-05	0.00109	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—SDHB—adrenal gland cancer	1.36e-05	0.00108	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PRKACA—adrenal gland cancer	1.35e-05	0.00107	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MEN1—adrenal gland cancer	1.34e-05	0.00107	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	1.32e-05	0.00105	CbGpPWpGaD
Propranolol—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	1.29e-05	0.00103	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—CDC42—adrenal gland cancer	1.29e-05	0.00103	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—GNRH1—adrenal gland cancer	1.27e-05	0.00101	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—MED12—adrenal gland cancer	1.27e-05	0.00101	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—MED12—adrenal gland cancer	1.27e-05	0.00101	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—POMC—adrenal gland cancer	1.27e-05	0.00101	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—CDC42—adrenal gland cancer	1.26e-05	0.001	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—GNRH1—adrenal gland cancer	1.25e-05	0.000991	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	1.24e-05	0.00099	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—RRM1—adrenal gland cancer	1.23e-05	0.000982	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—SDHD—adrenal gland cancer	1.23e-05	0.000982	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	1.23e-05	0.000981	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—GNAS—adrenal gland cancer	1.23e-05	0.00098	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—GNRH1—adrenal gland cancer	1.22e-05	0.00097	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—GNAS—adrenal gland cancer	1.2e-05	0.000958	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.19e-05	0.000943	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	1.18e-05	0.000937	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—CDC42—adrenal gland cancer	1.17e-05	0.000931	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—RRM1—adrenal gland cancer	1.17e-05	0.000928	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—SDHD—adrenal gland cancer	1.17e-05	0.000928	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.17e-05	0.000927	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SPRY2—adrenal gland cancer	1.16e-05	0.000927	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CDC42—adrenal gland cancer	1.16e-05	0.000927	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—SDHB—adrenal gland cancer	1.15e-05	0.000918	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—CDC42—adrenal gland cancer	1.14e-05	0.000911	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SPRY2—adrenal gland cancer	1.14e-05	0.000907	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TSHR—adrenal gland cancer	1.13e-05	0.000903	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IGF2—adrenal gland cancer	1.12e-05	0.000893	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—CDC42—adrenal gland cancer	1.12e-05	0.000891	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—GNAS—adrenal gland cancer	1.12e-05	0.00089	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SPRY2—adrenal gland cancer	1.11e-05	0.000887	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—GNAS—adrenal gland cancer	1.11e-05	0.000885	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TSHR—adrenal gland cancer	1.11e-05	0.000884	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—GNAS—adrenal gland cancer	1.09e-05	0.00087	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TSHR—adrenal gland cancer	1.09e-05	0.000864	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IGF1R—adrenal gland cancer	1.08e-05	0.000864	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.08e-05	0.000861	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—GNAS—adrenal gland cancer	1.07e-05	0.000851	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MEN1—adrenal gland cancer	1.07e-05	0.000849	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.06e-05	0.000844	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MEN1—adrenal gland cancer	1.04e-05	0.000831	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—POMC—adrenal gland cancer	1.04e-05	0.000828	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PRKACA—adrenal gland cancer	1.02e-05	0.000814	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MEN1—adrenal gland cancer	1.02e-05	0.000812	CbGpPWpGaD
Propranolol—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	9.96e-06	0.000793	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—RRM1—adrenal gland cancer	9.54e-06	0.000759	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—SDHD—adrenal gland cancer	9.54e-06	0.000759	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—POMC—adrenal gland cancer	9.45e-06	0.000752	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TERT—adrenal gland cancer	9.34e-06	0.000743	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—SDHD—adrenal gland cancer	9.31e-06	0.000741	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—RRM1—adrenal gland cancer	9.31e-06	0.000741	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	9.28e-06	0.000739	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PRKACA—adrenal gland cancer	9.27e-06	0.000738	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—MED12—adrenal gland cancer	9.2e-06	0.000732	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	9.08e-06	0.000723	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SDHB—adrenal gland cancer	8.9e-06	0.000709	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—RRM1—adrenal gland cancer	8.77e-06	0.000698	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—SDHD—adrenal gland cancer	8.77e-06	0.000698	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	8.76e-06	0.000698	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—MED12—adrenal gland cancer	8.69e-06	0.000692	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	8.68e-06	0.000691	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	8.4e-06	0.000669	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	8.36e-06	0.000666	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	8.29e-06	0.00066	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—POMC—adrenal gland cancer	8.29e-06	0.00066	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PRKACA—adrenal gland cancer	8.15e-06	0.000648	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—BAD—adrenal gland cancer	8.12e-06	0.000647	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—POMC—adrenal gland cancer	8.11e-06	0.000645	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	8.08e-06	0.000644	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PRKACA—adrenal gland cancer	7.97e-06	0.000634	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	7.93e-06	0.000631	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	7.79e-06	0.00062	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	7.77e-06	0.000618	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—GNAS—adrenal gland cancer	7.52e-06	0.000599	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—POMC—adrenal gland cancer	7.52e-06	0.000599	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—GNAS—adrenal gland cancer	7.51e-06	0.000598	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—POMC—adrenal gland cancer	7.49e-06	0.000596	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—SDHD—adrenal gland cancer	7.43e-06	0.000592	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—RRM1—adrenal gland cancer	7.43e-06	0.000592	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—BRAF—adrenal gland cancer	7.4e-06	0.000589	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	7.38e-06	0.000588	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ABCB1—adrenal gland cancer	7.37e-06	0.000587	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—POMC—adrenal gland cancer	7.36e-06	0.000586	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	7.2e-06	0.000573	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—EGFR—adrenal gland cancer	7.17e-06	0.000571	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—MED12—adrenal gland cancer	7.11e-06	0.000566	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	7.05e-06	0.000562	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	6.96e-06	0.000554	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—MED12—adrenal gland cancer	6.94e-06	0.000553	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CDC42—adrenal gland cancer	6.91e-06	0.00055	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CDC42—adrenal gland cancer	6.76e-06	0.000538	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	6.71e-06	0.000534	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IGF2—adrenal gland cancer	6.66e-06	0.00053	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	6.61e-06	0.000526	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—GNAS—adrenal gland cancer	6.6e-06	0.000526	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—MED12—adrenal gland cancer	6.54e-06	0.000521	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IGF2—adrenal gland cancer	6.51e-06	0.000519	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—GNAS—adrenal gland cancer	6.46e-06	0.000514	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IGF1R—adrenal gland cancer	6.44e-06	0.000513	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	6.37e-06	0.000507	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	6.36e-06	0.000506	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PRKACA—adrenal gland cancer	6.34e-06	0.000505	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	6.31e-06	0.000503	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IGF1R—adrenal gland cancer	6.3e-06	0.000501	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.2e-06	0.000493	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	6.16e-06	0.00049	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	6.05e-06	0.000482	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—RRM1—adrenal gland cancer	5.74e-06	0.000457	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SDHD—adrenal gland cancer	5.74e-06	0.000457	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	5.58e-06	0.000444	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TERT—adrenal gland cancer	5.54e-06	0.000441	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—MED12—adrenal gland cancer	5.54e-06	0.000441	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	5.51e-06	0.000439	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GNAS—adrenal gland cancer	5.44e-06	0.000433	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TERT—adrenal gland cancer	5.42e-06	0.000432	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CTNNB1—adrenal gland cancer	5.34e-06	0.000425	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	5.34e-06	0.000425	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	5.34e-06	0.000425	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	5.3e-06	0.000422	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	5.19e-06	0.000413	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GNAS—adrenal gland cancer	5.14e-06	0.000409	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	5.07e-06	0.000404	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—POMC—adrenal gland cancer	5.07e-06	0.000403	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PRKACA—adrenal gland cancer	5.06e-06	0.000403	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—POMC—adrenal gland cancer	5.06e-06	0.000403	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ABCB1—adrenal gland cancer	5.04e-06	0.000401	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.95e-06	0.000394	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—BAD—adrenal gland cancer	4.82e-06	0.000384	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	4.77e-06	0.00038	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—BAD—adrenal gland cancer	4.72e-06	0.000375	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	4.61e-06	0.000367	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—POMC—adrenal gland cancer	4.45e-06	0.000354	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—BRAF—adrenal gland cancer	4.39e-06	0.000349	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—POMC—adrenal gland cancer	4.35e-06	0.000346	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—BRAF—adrenal gland cancer	4.29e-06	0.000342	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—MED12—adrenal gland cancer	4.28e-06	0.00034	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—EGFR—adrenal gland cancer	4.25e-06	0.000339	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	4.25e-06	0.000338	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—EGFR—adrenal gland cancer	4.23e-06	0.000337	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GNAS—adrenal gland cancer	4.21e-06	0.000335	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	4.2e-06	0.000334	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—EGFR—adrenal gland cancer	4.16e-06	0.000331	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	4.13e-06	0.000328	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GNAS—adrenal gland cancer	4.1e-06	0.000327	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	4.07e-06	0.000324	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	4.04e-06	0.000322	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	4.04e-06	0.000322	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTGS2—adrenal gland cancer	4.03e-06	0.000321	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	3.98e-06	0.000317	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.95e-06	0.000315	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GNAS—adrenal gland cancer	3.87e-06	0.000308	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	3.8e-06	0.000302	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—POMC—adrenal gland cancer	3.66e-06	0.000292	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TP53—adrenal gland cancer	3.56e-06	0.000283	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—POMC—adrenal gland cancer	3.46e-06	0.000275	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GNAS—adrenal gland cancer	3.28e-06	0.000261	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	3.22e-06	0.000256	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CTNNB1—adrenal gland cancer	3.17e-06	0.000253	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	3.16e-06	0.000251	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	3.12e-06	0.000248	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CTNNB1—adrenal gland cancer	3.1e-06	0.000247	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	3.03e-06	0.000242	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	2.92e-06	0.000233	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—POMC—adrenal gland cancer	2.83e-06	0.000225	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—POMC—adrenal gland cancer	2.76e-06	0.00022	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTGS2—adrenal gland cancer	2.76e-06	0.00022	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	2.65e-06	0.000211	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—POMC—adrenal gland cancer	2.6e-06	0.000207	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GNAS—adrenal gland cancer	2.53e-06	0.000201	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGFR—adrenal gland cancer	2.51e-06	0.0002	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	2.48e-06	0.000198	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGFR—adrenal gland cancer	2.46e-06	0.000196	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	2.4e-06	0.000191	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	2.26e-06	0.00018	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—POMC—adrenal gland cancer	2.21e-06	0.000176	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTGS2—adrenal gland cancer	2.2e-06	0.000175	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TP53—adrenal gland cancer	2.11e-06	0.000168	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	2.08e-06	0.000165	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TP53—adrenal gland cancer	2.06e-06	0.000164	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	2.02e-06	0.000161	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	1.76e-06	0.00014	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.7e-06	0.000136	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	1.36e-06	0.000108	CbGpPWpGaD
